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often seen in effectively communicating this to treatment prac-
tices within the clinical community to the Primary Care Trust
(PCT) level. Such delays can result in the continued prescribing of
less cost-effective drugs. We, therefore, looked at several poten-
tial approaches to enhance communications through improved
user interface capabilities of existing Excel-based models. Three
approaches were considered, all utilising existing Windows-
based tools and programming languages: HTML, Visual Basic,
or HTML/Visual Basic (hybrid). RESULTS: We successfully
developed a two-step methodology, based on a HTML/
VisualBasic approach, which can be used to quickly develop
sophisticated graphical user interfaces directly within the struc-
ture of an existing economic model. The advantage of this novel
approach is that there is no longer a need to rely on full replica-
tions of models in a separate programming language (such as
shockwave), which carries consistency issues, or the limited basic
spreadsheet interface. Also, the approach can be applied itera-
tively during model design for submission to a regulatory body,
which is a more efﬁcient development process. CONCLUSIONS:
A new method of presenting pharmacoeconomic results has been
developed, which can be designed within existing Excel-based
economic models, providing an enhanced, user-friendly, interac-
tive tool which can replicate real-world prescribing patterns for a
given scenario. These tools can greatly improve communications
of economic and clinical messages to PCTs.
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OBJECTIVES: To determine whether the Social Security Institu-
tion of Turkey has an appropriate system to collect and process
data in order to conduct budget impact analysis. METHODS:
A literature review was conducted in order to specify the data
needed for budget impact studies. Then, interviews with the
personnel of the Monitoring and Evaluation Department and
Pharmaceuticals and Pharmacy Department in the Social Security
Institution were made. Besides, the literature concerning General
Health Insurance MEDULA system was reviewed. Data was
assessed in terms of its existence and accessibility. RESULTS:
After using Web Electronic Bill System (w-ELF) in 2006,
MEDULA was established in order to transfer data between
health care settings and general health insurance system in 2007
in Turkey. Currently, patient characteristics such as age and
gender, information regarding diagnosis, examination, consulta-
tion, analysis, operation, complications and pharmaceuticals and
medical supplies used can be recorded via MEDULA. However,
patients and number of patients who have a speciﬁc health con-
dition or who use a certain pharmaceutical product cannot be
determined via web services of the system. Similarly, costs paid
for a speciﬁc medical treatment cannot be identiﬁed via
MEDULA. On the other hand, it is indicated that there is a
project to determine number of patients who have a speciﬁc
health condition through the system. CONCLUSIONS:
Although there is relevant raw data, number of eligible people
with a speciﬁc indication, extent of implementation of a phar-
maceutical and incremental cost per patient which are necessary
for budget impact studies cannot be accessed through the existent
system in the Social Security Institution of Turkey. Thus, some
improvement in data processing is needed.
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OBJECTIVES: To determine a rule or the threshold beyond
which missing data affects utility estimates, thus requiring resort
to imputation techniques. This analysis examined UK data and is
based on patient and payers’ perspectives. This paper moves
beyond the now established consensus against listwise and pair-
wise deletion of missing data toward comparably simple methods
of analysis that achieve greater accuracy. METHODS: EuroQoL
EQ-5D measurements of health utility obtained by survey of
secondary care patients after hospitalisation were examined in
order to develop missing data thresholds beyond which overall
data quality would be compromised and thus imputation tech-
niques required. Using gender, index age, length of stay in hos-
pital, number of comorbidities, and cost of care, patients were
stratiﬁed according to a primary diagnoses of 5 major chronic
conditions, in terms of cost. Each dataset, consisting of between
150 and 450 patients, was randomly assigned missing values,
based on two broad classes of randomness in the literature:
missing at random data and not missing at random data. Not
missing at random data was deﬁned as data containing paired
variables with correlation coefﬁcients of great than 0.50. Com-
parisons among primary ICD-10 diagnoses set at 5%, 10%,
15%, and 20% were examined. The missing data threshold for
each diagnosis was then calculated by model simulation using
various degrees of missing data. RESULTS: For cardiovascular
diseases, the missing data threshold was between 8.5% and 12%.
Rates of missingness beyond these levels tended to decrease the
accuracy of utility measures when compared with the full base-
line dataset. For diabetes, chronic pulmonary disease, and mus-
cular skeletal disorders, the range was lower. Therefore, for a
given cost of care, cost-utility ratios decline due to the increase in
uncertainty of the estimates. CONCLUSIONS: Descriptive mea-
sures of health status are affected by diagnosis and other factors.
The development of a rule that enables researchers to determine
whether missing data is likely to have a material effect on the
measurement of health status can lead to improved research
quality and, in turn, better allocation of health care resources.
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OBJECTIVES: To provide a ready-to-use framework for com-
puting the social discount rate, the proper rate for discounting of
social programmes, including health care programmes, given the
inoptimality of market mechanisms to derive the optimal dis-
count rate. METHODS: A social time preference methodology
derived from Feldstein work (“The derivation of social time
preference rates”, Kyklos 18, 1965) is applied to calculate social
discount rates as social time preference (STP) rates across 167
countries for a speciﬁc year (2006) and across time from 2005–
2050 for a country case (Brazil). STR rate derived is deﬁned as
dt = (1 + pt)1-a(1 + gt)s(1 + r) - 1, where a is the population
weight, p the population growth, g the per-capita income growth,
s the coeffcient of risk aversion and r the pure time preference
rate. Data were obtained in the literature and databases (World
Development Indicators (World Bank, 2007), World Economic
Outlook (IMF, 2007) and IBGE (Instituto Brasileiro de Geograﬁa
A560 Abstracts
